Score 8.2 (out of 10): BIOTECH ETF could rise +19.4% over next 3 months

62

Insight:

SPDR S&P BIOTECH ETF appears to have reached a potential bottom. During similar occasions, SPDR S&P BIOTECH ETF had a median return of 19.4%, over the following 3 months – based on 10 historical occasions with 8 of those showing positive returns (80%). This buy signal for SPDR S&P BIOTECH ETF received a high score of 8.2 (out of 10).

Story:

Recently biotech sector analysts indicated deal making may start to accelerate as big pharma and biotech companies flush with cash may now go after targets with stock prices that have appeared to settle amid a dearth of deals.

Details:

NameSPDR S&P BIOTECH ETF
ViewUp
Star (1 to 10)8.2
Target+19.4%
Time3 months
Hit Rate80%

Leave a Reply